Interferon-γ capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation

Br J Haematol. 2013 May;161(3):449-52. doi: 10.1111/bjh.12251. Epub 2013 Feb 22.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenovirus Infections, Human / drug therapy
  • Adenovirus Infections, Human / etiology
  • Adenovirus Infections, Human / therapy*
  • Adenovirus Infections, Human / transmission
  • Adenoviruses, Human / immunology
  • Adolescent
  • Antigens, Viral / immunology
  • Antiviral Agents / therapeutic use
  • Capsid Proteins / immunology
  • Child
  • Chromatography, Liquid
  • Cidofovir
  • Combined Modality Therapy
  • Cytosine / analogs & derivatives
  • Cytosine / therapeutic use
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immunologic Deficiency Syndromes / complications
  • Immunologic Deficiency Syndromes / surgery
  • Immunomagnetic Separation / methods*
  • Immunosuppressive Agents / adverse effects
  • Immunotherapy, Adoptive*
  • Infant
  • Infant, Newborn
  • Interferon gamma Receptor
  • Interferon-gamma*
  • Lymphocyte Transfusion
  • Organophosphonates / therapeutic use
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery
  • Receptors, Interferon / metabolism
  • Ribavirin / therapeutic use
  • T-Cell Antigen Receptor Specificity
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / transplantation*
  • Transplantation, Homologous / adverse effects
  • Viremia / drug therapy
  • Viremia / etiology
  • Viremia / therapy*
  • Viremia / virology

Substances

  • Antigens, Viral
  • Antiviral Agents
  • Capsid Proteins
  • Immunosuppressive Agents
  • Organophosphonates
  • Receptors, Interferon
  • hexon capsid protein, Adenovirus
  • Ribavirin
  • Interferon-gamma
  • Cytosine
  • Cidofovir